Status:
COMPLETED
Prospective Data Analysis of a Quality Improvement Initiative in High Risk Cardiac Surgery Patients
Lead Sponsor:
Loma Linda University
Collaborating Sponsors:
Edwards Lifesciences
Conditions:
Coronary Artery Bypass Graft
Eligibility:
All Genders
18+ years
Brief Summary
This project is designed to assess the impact of implementing a hemodynamic optimization protocol, utilizing flow guided parameters that is provided by technology from Edwards Lifesciences, for patien...
Eligibility Criteria
Inclusion
- (1) the procedure was a first-start case, (2) the procedure was scheduled, (3) the procedure is considered non-emergent, and (4) the cardiac surgery required cardiopulmonary bypass
Exclusion
- (1) Patients less than 18 years of age, (2) failure to undergo CPB, (3) non-first-start or emergent classification, (4) as well those who did not receive at least 12 hours of inotropic and/or vasoconstrictive agents were excluded from the study.
Key Trial Info
Start Date :
January 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT04458701
Start Date
January 17 2019
End Date
June 30 2020
Last Update
August 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Medical Center
Loma Linda, California, United States, 92354